Results 11 to 20 of about 16,224,526 (223)

Diagnostics in Pleural Disease [PDF]

open access: yesDiagnostics, 2020
Pleural disease diagnostics represent a sprawling topic that has enjoyed a renaissance in recent years from humble beginnings. Whilst pleural patients are heterogeneous as a population and in the aetiology of the disease with which they present, we ...
A. Sundaralingam, E. Bedawi, N. Rahman
semanticscholar   +6 more sources

Malignant pleural disease [PDF]

open access: yesBreathe, 2023
Malignant pleural disease represents a growing healthcare burden. Malignant pleural effusion affects approximately 1 million people globally per year, causes disabling breathlessness and indicates a shortened life expectancy.
Laura M. Piggott   +3 more
semanticscholar   +4 more sources

Pleural Disease

open access: yesEvidence-Based Critical Care, 2020
This Monograph provides the clinician with an up-to-date summary of the substantial evidence in our understanding of pleural disease. It covers key aspects relevant to clinicians, including mechanisms, pathophysiology, epidemiology, diagnostics, relevant experimental models and interventions.
J. Cárdenas-García, Fabien Maldonado
semanticscholar   +6 more sources

Management of complex pleural disease in the critically ill patient [PDF]

open access: yesJ Thorac Dis, 2021
Disorders of the pleural space are quite common in the critically ill patient. They are generally associated with the underlying illness. It is sometimes difficult to assess for pleural space disorders in the ICU given the instability of some patients ...
K. Hu, A. Chopra, J. Kurman, J. Huggins
semanticscholar   +2 more sources

A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab [PDF]

open access: yesCancer Discov, 2021
Malignant pleural diseases, comprising metastatic lung and breast cancers and malignant pleural mesothelioma (MPM), are aggressive solid tumors with poor therapeutic response.
P. Adusumilli   +29 more
semanticscholar   +2 more sources

Frailty Prevalence and Association with Clinical Outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease [PDF]

open access: yesGeriatrics, 2023
Background: Frailty is a syndrome characterised by increased vulnerability to negative outcomes. Interstitial lung disease (ILD), asthma, and pleural disease are leading causes of morbidity and mortality. We aimed to investigate the prevalence and impact
Alessia Verduri   +7 more
doaj   +2 more sources

Thoracic ultrasound in the modern management of pleural disease [PDF]

open access: yesEur Respir Rev, 2020
Physician-led thoracic ultrasound (TUS) has substantially changed how respiratory disorders, and in particular pleural diseases, are managed. The use of TUS as a point-of-care test enables the respiratory physician to quickly and accurately diagnose ...
Maged Hassan, R. Mercer, N. Rahman
semanticscholar   +2 more sources

Imaging of Pleural Disease

open access: yesClinics in Chest Medicine, 2006
Imaging plays an important role in the diagnosis and subsequent management of patients with pleural disease. The presence of a pleural abnormality is usually suggested following a routine chest x-ray, with a number of imaging modalities available for further characterization.
Qureshi, N, Gleeson, F
openaire   +4 more sources

Pleural Disease

open access: yes, 2013
The most frequent benign pleural disease is pleural effusion; other benign conditions involving the pleura include empyema, pneumothorax, pleural plaques, and fibrothorax. Malignant pleural disease is a common clinical problem, as about 25 % of all pleural effusions in elderly patients have a neoplastic origin.
Feragalli, Beatrice   +6 more
openaire   +4 more sources

IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: a case report [PDF]

open access: yesBMC Pulm Med, 2020
Background Immune checkpoint inhibitors (ICIs) are the standard treatment for non-small cell lung cancer. The unique adverse events that can arise after treatment with ICIs are known as immune-related adverse events (irAE).
T. Terashima   +7 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy